(MedPage Today) — An estimated 20% to 40% of patients with HER2-positive metastatic breast cancer will ultimately develop brain metastases, resulting in poorer odds of survival along with headache, seizure, neurological and cognitive impairment…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
